Table 3 Low-density lipoprotein cholesterol (LDL-C) goal attainment of the ACS population with at least one LDL-C measurements during index hospitalization and alive 28 days after index hospitalization (N = 2887) stratified by baseline comorbidity (diabetes mellitus and/or chronic kidney disease). LDL-C level (LDL-C < 1.8 mmol/L, LDL-C ≥ 1.8 mmol/L, no measurement) given by number and percentage (N, %) if nothing else is indicated (1 January 2010–31 December 2015)
Comorbidity | Total | ACS population, N = 2887 | ||
|---|---|---|---|---|
LDL-C (mmol/L) | ||||
< 1.8 | ≥ 1.8 | No | ||
Comorbidity at inclusion (diabetes mellitus and/or chronic kidney disease) | ||||
LDL-C measurement at | ||||
Index hospitalization | 477 | 104 (24.2) | 325 (75.8) | 48 |
6-month follow-up | 417 | 168 (49.7) | 170 (50.3) | 79 |
12-month follow-up | 381 | 128 (51.8) | 119 (48.2) | 134 |
No comorbidity at inclusion | ||||
LDL-C measurement at | ||||
Index hospitalization | 2410 | 115 (7.8) | 1350 (92.2) | 945 |
6-month follow-up | 2239 | 684 (38.7) | 1085 (61.3) | 470 |
12-month follow-up | 2164 | 455 (36.5) | 793 (63.5) | 916 |